Commentary: Nicotine replacement therapy for smoking cessation

International Journal of Epidemiology

Volumn 34, Issue 5, 2005, Pages 1002-

  Hughes, John R ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NON PRESCRIPTION DRUG;

HEALTH AND DISEASE;

ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH HAZARD; HEALTH PROMOTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NICOTINE REPLACEMENT THERAPY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SAFETY; SMOKING CESSATION; SYSTEMATIC REVIEW; TAX; TOBACCO DEPENDENCE;

EID: 27544469746     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyi171     Document Type: Article

References (2)

1. Murray JL, Lopez AD. Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-15.
2. Hughes JR, Carpenter MJ. The feasibility of smoking reduction: An update. Addiction 2005;100:1074-89.